← back to search

Claus L. Andersen

Odense University Hospital · DK
🔎 Find collaborators in Cancer Research · Pathology and Forensic Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Pathology and Forensic Medicine
Research interest
Research interests include Cancer Genomics and Diagnostics, Genetic factors in colorectal cancer, MicroRNA in disease regulation, and Cancer-related molecular mechanisms research.
h-index
60
citations
25,157
works
396
NIH funding
primary concept
Medicine
email

Recent publications

Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
Nature Medicine 2024cited by 91position: middledoi
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers
Cancer Discovery 2024cited by 50position: middledoi
Detection and characterization of lung cancer using cell-free DNA fragmentomes
Nature Communications 2021cited by 452position: middledoi
Genome-wide cell-free DNA fragmentation in patients with cancer
Nature 2019cited by 1,440position: middledoi
Direct detection of early-stage cancers using circulating tumor DNA
Science Translational Medicine 2017cited by 1,144position: middledoi
An Optimized Shotgun Strategy for the Rapid Generation of Comprehensive Human Proteomes
Cell Systems 2017cited by 549position: middledoi
The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progression
Nature Communications 2017cited by 70position: middledoi
SNHG16 is regulated by the Wnt pathway in colorectal cancer and affects genes involved in lipid metabolism
Molecular Oncology 2016cited by 227position: lastdoi
A Dual Program for Translation Regulation in Cellular Proliferation and Differentiation
Cell 2014cited by 510position: middledoi
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
Nature Communications 2014cited by 118position: middledoi
Mnk2 Alternative Splicing Modulates the p38-MAPK Pathway and Impacts Ras-Induced Transformation
Cell Reports 2014cited by 116position: middledoi
The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis
Cell Death and Differentiation 2013cited by 59position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jesper B. Bramsen · Aarhus University3 papers (2016–2017)Lars Dyrskjøt · Aarhus University2 papers (2013–2014)Halit Ongen · University of Geneva2 papers (2016–2017)Anders H. Lund · University of Copenhagen2 papers (2014–2016)Jakob Skou Pedersen · Aarhus University2 papers (2014–2016)Karina D. Sørensen · Aarhus University2 papers (2014–2017)Emmanouil T. Dermitzakis · SIB Swiss Institute of Bioinformatics2 papers (2016–2017) · 2 papers (2014–2016)Torben Ørntoft · Center for Cancer Research2 papers (2013–2014)Torben F. Ørntoft · Aarhus University2 papers (2016–2017)Jesper V. Olsen · University of Copenhagen1 papers (2017–2017) · 1 papers (2014–2014)Michalis Liontos · Hellenic Oncology Research Group1 papers (2013–2013)Sebastian M. Waszak · University Hospital Heidelberg1 papers (2014–2014)Regina Golan‐Gerstl · Hebrew University of Jerusalem1 papers (2014–2014)Athanassios Kotsinas · Indiana University School of Medicine1 papers (2013–2013) · 1 papers (2014–2014) · 1 papers (2014–2014) · 1 papers (2017–2017)Christian D. Kelstrup · Novo Nordisk (Denmark)1 papers (2017–2017)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Pathology and Forensic Medicine →